Beyond Air, Inc. (XAIR)
NASDAQ: XAIR · Real-Time Price · USD
2.190
+1.314 (150.00%)
At close: Jan 13, 2026, 4:00 PM EST
2.030
-0.160 (-7.31%)
After-hours: Jan 13, 2026, 7:59 PM EST
Beyond Air Market Cap
Beyond Air has a market cap or net worth of $17.54 million as of January 13, 2026. Its market cap has decreased by -42.30% in one year.
Market Cap
17.54M
Enterprise Value
20.64M
1-Year Change
-42.30%
Ranking
Category
Stock Price
$2.19
Market Cap Chart
Since May 8, 2019, Beyond Air's market cap has decreased from $50.50M to $17.54M, a decrease of -65.27%. That is a compound annual growth rate of -14.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 12, 2026 | 7.00M | 20.69% |
| Dec 31, 2025 | 5.80M | -77.61% |
| Dec 31, 2024 | 25.90M | -58.69% |
| Dec 29, 2023 | 62.70M | -67.70% |
| Dec 30, 2022 | 194.10M | -22.82% |
| Dec 31, 2021 | 251.50M | 175.16% |
| Dec 31, 2020 | 91.40M | 62.63% |
| Dec 31, 2019 | 56.20M | 11.29% |
| May 8, 2019 | 50.50M | - |
View and export this data all the way back to 2019. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.91B |
| Johnson & Johnson | 505.28B |
| AbbVie | 388.90B |
| UnitedHealth Group | 308.45B |
| AstraZeneca | 294.97B |
| Novartis AG | 274.30B |
| Merck & Co. | 271.01B |
| Novo Nordisk | 263.26B |